Pharma company drastically boosts its potential coronavirus vaccine production

Berlin German pharmaceutical company BioNTech, which is currently developing a possible vaccine against the novel coronavirus together with US drug giant Pfizer, announced Thursday it was buying a new production plant in order drastically to increase its production capacities.

BioNTech said the acquisition of the vaccine plant in Marburg, Germany, from the pharmaceutical firm Novartis, would allow it to produce tens of millions more vaccine doses a month -- pending regulatory approval -- from next year.The plant is expected to be fully operational in the first half of 2021, BioNTech said in a news release, and will retain its existing, highly skilled workforce of 300 employees following the transfer from Novartis later this year.

Has Trump done anything to piss off Germany yet?

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Caffeine company wants to help people sleep with new drink - CNN VideoPepsiCo built a massive multinational business by putting pep in people's steps. Now it's unveiling Driftwell, a new drink enhanced with ingredients to promote relaxation and to help ease stress, and the internet has a new name for it. Jeanne Moos reports. I’m still waiting for soup bags. CocaCola reading this Want
출처: CNN - 🏆 4. / 95 더 많은 것을 읽으십시오 »